NEW YORK (GenomeWeb) — Kapa Biosystems said today that it has signed a three-year exclusive distribution agreement with Nippon Genetics.

The agreement extends an existing seven-year relationship between the companies and enables Nippon to continue marketing, distributing, and servicing Kapa's genomics reagents in Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.